Cargando…
Activin E–ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice
Body fat distribution is a heritable risk factor for cardiovascular and metabolic disease. In humans, rare Inhibin beta E (INHBE, activin E) loss-of-function variants are associated with a lower waist-to-hip ratio and protection from type 2 diabetes. Hepatic fatty acid sensing promotes INHBE express...
Autores principales: | Adam, Rene C., Pryce, Dwaine S., Lee, Joseph S., Zhao, Yuanqi, Mintah, Ivory J., Min, Soo, Halasz, Gabor, Mastaitis, Jason, Atwal, Gurinder S., Aykul, Senem, Idone, Vincent, Economides, Aris N., Lotta, Luca A., Murphy, Andrew J., Yancopoulos, George D., Sleeman, Mark W., Gusarova, Viktoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410708/ https://www.ncbi.nlm.nih.gov/pubmed/37523551 http://dx.doi.org/10.1073/pnas.2309967120 |
Ejemplares similares
-
Activin A forms a non-signaling complex with ACVR1 and type II Activin/BMP receptors via its finger 2 tip loop
por: Aykul, Senem, et al.
Publicado: (2020) -
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022) -
Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B
por: Olsen, Oddrun Elise, et al.
Publicado: (2015) -
The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva
por: Wolken, Dana M. Alessi, et al.
Publicado: (2017) -
Characterization of Fibrodysplasia Ossificans Progessiva relevant Acvr1/Acvr2 Activin receptors in medaka (Oryzias latipes)
por: Trumpp, Michael, et al.
Publicado: (2023)